APA (7th ed.) Citation

Hufnagl, C., Leisch, M., Weiss, L., Melchardt, T., Moik, M., Asslaber, D., . . . Egle, A. (2020). Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer. Oncology Letters, 19(2), 1551. https://doi.org/10.3892/ol.2019.11192

Chicago Style (17th ed.) Citation

Hufnagl, Clemens, et al. "Evaluation of Circulating Cell-free DNA as a Molecular Monitoring Tool in Patients with Metastatic Cancer." Oncology Letters 19, no. 2 (2020): 1551. https://doi.org/10.3892/ol.2019.11192.

MLA (9th ed.) Citation

Hufnagl, Clemens, et al. "Evaluation of Circulating Cell-free DNA as a Molecular Monitoring Tool in Patients with Metastatic Cancer." Oncology Letters, vol. 19, no. 2, 2020, p. 1551, https://doi.org/10.3892/ol.2019.11192.